Commentary on Eosinophilic Inflammation, Coronavirus Disease 2019, and Asthma: Are inhaled corticosteroids the missing link?
作者信息
Ho Kam Sing, Howell Daniel, Rogers Linda, Narasimhan Bharat, Verma Hannah, Steiger David
机构信息
Department of Medicine, Mount Sinai Morningside and Mount Sinai West Hospitals, Icahn School of Medicine at Mount Sinai, New York, New York.
Department of Pulmonary and Critical Care, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York.
出版信息
Ann Allergy Asthma Immunol. 2021 Aug;127(2):279. doi: 10.1016/j.anai.2021.04.039. Epub 2021 May 8.
Abstract
摘要
相似文献
1
Commentary on Eosinophilic Inflammation, Coronavirus Disease 2019, and Asthma: Are inhaled corticosteroids the missing link?关于嗜酸性粒细胞炎症、2019冠状病毒病和哮喘的评论：吸入性糖皮质激素是缺失的环节吗？
Ann Allergy Asthma Immunol. 2021 Aug;127(2):279. doi: 10.1016/j.anai.2021.04.039. Epub 2021 May 8.
2
Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?嗜酸性粒细胞炎症、2019冠状病毒病与哮喘：吸入性糖皮质激素是其中的缺失环节吗？
Ann Allergy Asthma Immunol. 2021 Aug;127(2):278. doi: 10.1016/j.anai.2021.03.029.
3
Asthma and COVID-19: an update.哮喘与 COVID-19：最新进展。
Eur Respir Rev. 2021 Dec 15;30(162). doi: 10.1183/16000617.0152-2021. Print 2021 Dec 31.
4
Inhaled corticosteroids for the treatment of COVID-19.吸入性皮质类固醇治疗 COVID-19。
Eur Respir Rev. 2022 Nov 29;31(166). doi: 10.1183/16000617.0099-2022. Print 2022 Dec 31.
5
Asthma, biologics, corticosteroids, and coronavirus disease 2019.哮喘、生物制剂、皮质类固醇与2019冠状病毒病
Ann Allergy Asthma Immunol. 2020 Jul;125(1):12-13. doi: 10.1016/j.anai.2020.05.001. Epub 2020 May 6.
6
COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?新型冠状病毒肺炎、哮喘与吸入性糖皮质激素：吸入性糖皮质激素的又一有益作用？
Am J Respir Crit Care Med. 2020 Jul 1;202(1):8-10. doi: 10.1164/rccm.202005-1651ED.
7
Attenuating COVID-19 infection and inflammation: Lessons from asthma.减轻新型冠状病毒肺炎感染与炎症：哮喘带来的启示
Respirology. 2020 Dec;25(12):1233-1234. doi: 10.1111/resp.13961. Epub 2020 Oct 13.
8
Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network.儿童哮喘患者感染 SARS-CoV-2：来自全球哮喘网络的证据。
Pediatr Allergy Immunol. 2022 Jan;33(1):e13709. doi: 10.1111/pai.13709. Epub 2021 Dec 11.
9
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.COVID-19 风险和结局在接受生物制剂或全身皮质类固醇治疗的成年哮喘患者中的：全国真实世界证据。
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13. doi: 10.1016/j.jaci.2021.06.006. Epub 2021 Jun 15.
10
Common concerns in managing bronchial asthma during the COVID-19 pandemic.在新冠疫情期间管理支气管哮喘的常见问题。
Int J Tuberc Lung Dis. 2020 Jul 1;24(7):750-752. doi: 10.5588/ijtld.20.0378.
本文引用的文献
1
Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?嗜酸性粒细胞炎症、2019冠状病毒病与哮喘：吸入性糖皮质激素是其中的缺失环节吗？
Ann Allergy Asthma Immunol. 2021 Aug;127(2):278. doi: 10.1016/j.anai.2021.03.029.
2
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.吸入用布地奈德治疗早期 COVID-19（STOIC）：一项 2 期、开放标签、随机对照试验。
Lancet Respir Med. 2021 Jul;9(7):763-772. doi: 10.1016/S2213-2600(21)00160-0. Epub 2021 Apr 9.
3
Impact of corticosteroids in hospitalised COVID-19 patients.COVID-19 住院患者中皮质类固醇的影响。
BMJ Open Respir Res. 2021 Apr;8(1). doi: 10.1136/bmjresp-2020-000766.
4
The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection.哮喘、嗜酸性粒细胞增多与 2019 冠状病毒病感染结局的关系。
Ann Allergy Asthma Immunol. 2021 Jul;127(1):42-48. doi: 10.1016/j.anai.2021.02.021. Epub 2021 Feb 27.
5
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联：一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
6
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.COVID-19 住院和非住院患者中哮喘的患病率和特征。
J Allergy Clin Immunol. 2020 Aug;146(2):307-314.e4. doi: 10.1016/j.jaci.2020.06.010. Epub 2020 Jun 15.
7
Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.格隆溴铵、福莫特罗和布地奈德对人鼻和气管上皮细胞原代培养物中冠状病毒HCoV-229E复制及细胞因子产生的抑制作用。
Respir Investig. 2020 May;58(3):155-168. doi: 10.1016/j.resinv.2019.12.005. Epub 2020 Feb 21.
8
Asthma: the interplay between viral infections and allergic diseases.哮喘：病毒感染与过敏性疾病之间的相互作用
Immunol Allergy Clin North Am. 2015 Feb;35(1):115-27. doi: 10.1016/j.iac.2014.09.012. Epub 2014 Nov 21.
Zotero 插件